ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026)
ClearPoint Neuro (CLPT) reported EBT Margin of 78.69% for Q1 2026, down 789.0% on a YoY basis from 11.42% in Q1 2025, and down 5.27% sequentially from 74.76% in Q4 2025.
ClearPoint Neuro (CLPT) EBT Margin (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of EBT Margin data on file, last reported at 78.69% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 789.0% year-over-year to 78.69%; the trailing twelve-month figure through Mar 2026 stood at 71.46% (down 700.0% YoY), and the FY2025 full-year result was 68.93%, down 872.0% from the prior year.
- EBT Margin eased to 78.69% in Q1 2026, from 74.76% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 54.08% in Q1 2024 to a low of 282.37% in Q2 2022.
- A 5-year average of 116.96% and a median of 74.76% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin jumped 36216 bps in 2022 and slumped 1673 bps in 2025, its largest moves.
- Tracing CLPT's EBT Margin over 5 years: stood at 89.7% in 2022, then increased by 20 bps to 71.88% in 2023, then climbed by 3 bps to 69.72% in 2024, then decreased by 7 bps to 74.76% in 2025, then slipped by 5 bps to 78.69% in 2026.
- Business Quant data shows CLPT's EBT Margin at 78.69% in Q1 2026, 74.76% in Q4 2025, and 66.39% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -78.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.69% |
| Dec 31, 2025 | -74.76% |
| Sep 30, 2025 | -66.39% |
| Jun 30, 2025 | -63.07% |
| Mar 31, 2025 | -70.81% |
| Dec 31, 2024 | -69.72% |
| Sep 30, 2024 | -61.07% |
| Jun 30, 2024 | -55.90% |
| Mar 31, 2024 | -54.08% |
| Dec 31, 2023 | -71.88% |
| Sep 30, 2023 | -117.39% |
| Jun 30, 2023 | -188.71% |
| Mar 31, 2023 | -203.35% |
| Dec 31, 2022 | -89.70% |
| Sep 30, 2022 | -214.65% |
| Jun 30, 2022 | -282.37% |
| Mar 31, 2022 | -225.86% |
| Dec 31, 2021 | -95.38% |
| Sep 30, 2021 | -418.28% |
| Jun 30, 2021 | -536.86% |